Pär Westlund

849 total citations
26 papers, 679 citations indexed

About

Pär Westlund is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, Pär Westlund has authored 26 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Biochemistry and 5 papers in Molecular Biology. Recurrent topics in Pär Westlund's work include Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Alcohol Consumption and Health Effects (4 papers). Pär Westlund is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Eicosanoids and Hypertension Pharmacology (8 papers) and Alcohol Consumption and Health Effects (4 papers). Pär Westlund collaborates with scholars based in Sweden, Switzerland and United States. Pär Westlund's co-authors include Elisabeth Granström, M.L. Swahn, M. Bygdeman, Maria Kumlin, Anna Nordenström, Bengt Samuelsson, Patrick Y.-K. Wong, Mats Hámberg, Elisabeth Johannisson and Markku Seppälä and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Lipid Research.

In The Last Decade

Pär Westlund

26 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pär Westlund Sweden 13 178 157 142 135 126 26 679
Ralf Miesel Germany 20 200 1.1× 32 0.2× 53 0.4× 140 1.0× 181 1.4× 39 931
K. Gréen Sweden 10 47 0.3× 85 0.5× 246 1.7× 144 1.1× 38 0.3× 16 540
Joseph Krasner United States 15 31 0.2× 46 0.3× 45 0.3× 50 0.4× 40 0.3× 40 600
Antonio J. Ruiz‐Alcaraz Spain 19 237 1.3× 24 0.2× 23 0.2× 62 0.5× 168 1.3× 52 1.1k
P.J. Meier Switzerland 14 25 0.1× 144 0.9× 88 0.6× 49 0.4× 17 0.1× 20 1.4k
W.H.M. Peters Netherlands 13 33 0.2× 57 0.4× 21 0.1× 197 1.5× 165 1.3× 29 754
Dean P. Jones United States 7 36 0.2× 68 0.4× 13 0.1× 74 0.5× 59 0.5× 8 426
Maria Hedelin Sweden 16 163 0.9× 19 0.1× 34 0.2× 146 1.1× 13 0.1× 25 984
Claude Vieu France 14 22 0.1× 116 0.7× 15 0.1× 43 0.3× 42 0.3× 20 716
N. T. Shahidi United States 14 43 0.2× 15 0.1× 78 0.5× 34 0.3× 26 0.2× 38 950

Countries citing papers authored by Pär Westlund

Since Specialization
Citations

This map shows the geographic impact of Pär Westlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pär Westlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pär Westlund more than expected).

Fields of papers citing papers by Pär Westlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pär Westlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pär Westlund. The network helps show where Pär Westlund may publish in the future.

Co-authorship network of co-authors of Pär Westlund

This figure shows the co-authorship network connecting the top 25 collaborators of Pär Westlund. A scholar is included among the top collaborators of Pär Westlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pär Westlund. Pär Westlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stygar, Denis, Pär Westlund, Håkan Eriksson, & Lena Sahlin. (2005). Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes. Clinical Endocrinology. 64(1). 74–81. 46 indexed citations
2.
Stavreus‐Evers, Anneli, et al.. (2005). Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary. Fertility and Sterility. 83(1). 156–162. 29 indexed citations
3.
Westlund, Pär, et al.. (1999). Eicosanoid Metabolism in Human Platelets is Modified by Albumin. Advances in experimental medicine and biology. 469. 23–27. 1 indexed citations
4.
Westlund, Pär, et al.. (1999). Albumin modifies the metabolism of hydroxyeicosatetraenoic acids via 12-lipoxygenase in human platelets. Journal of Lipid Research. 40(5). 940–947. 9 indexed citations
6.
Granström, Elisabeth, et al.. (1998). 12-Hydroxyeicosatetraenoic Acid is a Long-Lived Substance in the Rabbit Circulation. Prostaglandins & Other Lipid Mediators. 55(1). 3–25. 5 indexed citations
7.
Granström, Elisabeth, et al.. (1996). Albumin prevents metabolism of 12-hydroxyeicosatetraenoic acid by leukocytes in vitro. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1303(2). 154–160. 5 indexed citations
8.
Gemzell‐Danielsson, Kristina, Pär Westlund, E. Johannisson, et al.. (1996). Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Human Reproduction. 11(2). 256–264. 85 indexed citations
9.
Swahn, M.L., Pär Westlund, Elisabeth Johannisson, & M. Bygdeman. (1996). Effect of post‐coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstetricia Et Gynecologica Scandinavica. 75(8). 738–744. 76 indexed citations
10.
Gemzell‐Danielsson, Kristina, Pär Westlund, E. Johannisson, et al.. (1996). Effect of Low Weekly Doses of Mifepristone on Ovarian Function and Endometrial Development. Obstetrical & Gynecological Survey. 51(9). 544–546. 7 indexed citations
11.
Westlund, Pär, et al.. (1995). Kinetic and structural evidence for the identification of 11-hydroxythromboxane B2 dehydrogenase as cytosolic aldehyde dehydrogenase. Prostaglandins. 50(5-6). 287–299. 1 indexed citations
12.
Swahn, M.L., László Kovács, S.Z. Cekan, A.-R. Aedo, & Pär Westlund. (1994). Termination of early pregnancy with ZK 98, 734: pharmacokinetic behaviour and clinical effect. Human Reproduction. 9(1). 57–63. 6 indexed citations
13.
Westlund, Pär, et al.. (1994). 11‐Hydroxythromboxane B2 dehydrogenase is identical to cytosolic aldehyde dehydrogenase. FEBS Letters. 345(2-3). 99–103. 14 indexed citations
14.
Westlund, Pär. (1993). Purification and some properties of 11‐hydroxythromboxane B2 dehydrogenase from porcine kidney. European Journal of Biochemistry. 212(2). 403–409. 4 indexed citations
15.
Westlund, Pär, Jan Palmblad, John R. Falck, & Sun Lumin. (1991). Synthesis, structural identification and biological activity of 11,12-dihydroxyeicosatetraenoic acids formed in human platelets. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1081(3). 301–307. 6 indexed citations
16.
Jönsson, E., Pär Westlund, K. C. Nicolaou, & Sven‐Erik Dahlén. (1989). Lipoxin A4 causes generation of thromboxane A2 in the guinea-pig lung. Inflammation Research. 26(1-2). 90–92. 9 indexed citations
17.
Dahlén, Barbro, Johan Raud, T Björck, et al.. (1988). Actions of Lipoxin A4 and Related Compounds in Smooth Muscle Preparations and on the Microcirculation in Vivo. PubMed. 229. 107–130. 45 indexed citations
18.
Westlund, Pär, Charlotte Edenius, & Jan Lindgren. (1988). Evidence for a novel pathway of leukotriene formation in human platelets. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 962(1). 105–115. 8 indexed citations
19.
Westlund, Pär, Maria Kumlin, Anna Nordenström, & Elisabeth Granström. (1986). Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. Prostaglandins. 31(3). 413–443. 44 indexed citations
20.
Wong, Patrick Y.-K., et al.. (1984). Omega-hydroxylation of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid in human polymorphonuclear leukocytes.. Journal of Biological Chemistry. 259(4). 2683–2686. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026